Skip to content
Bristol-Myers Squibb (BMS) has created the Disability Diversity in Clinical Trials (DDiCT) program to promote fair access to clinical trials and to ensure that […]
Bristol Myers Squibb launches program to promote disability diversity in clinical trials Read More »
The Supreme Court’s Dobbs v. Jackson decision is having farther-reaching effects than many expected, including on patients treating autoimmune disorders. As we’ve reported, access
How Dobbs v. Jackson affects patients treating autoimmune disorders Read More »
Monkeypox has officially been declared a Public Health Emergency of International Concern (PHEIC) by the World Health Organization, with a worldwide total of “16,000
WHO declares monkeypox a global ‘health emergency’ Read More »
U.S. President Joe Biden tested positive for COVID-19 on Thursday and is isolating in the White House with mild symptoms. He contracted the Omicron
President Biden’s mild symptoms show benefits of COVID-19 vaccine, boosters Read More »
What is the value of a treatment? As of July, the U.S. government has given out close to 600 million doses of COVID-19 vaccines
Efforts at value-based care focus on patients’ needs Read More »
There have been concerns about access to medical care and medication in the wake of the Dobbs v. Jackson decision by the Supreme Court.
House passes bill to protect access to contraception Read More »
We have to ensure the Biomedical Advanced Research and Development Authority (BARDA) “is properly funded so that it can continue to strengthen our preparedness
Funding BARDA is key to pandemic preparedness – here’s why Read More »
According to a study published earlier this year in The Lancet, antimicrobial-resistant infections have become a leading global cause of mortality. The study showed
AMR could be worse than the COVID-19 pandemic, experts say Read More »
“The COVID-19 pandemic pushed back years of progress made combating antimicrobial resistance (AMR) in the United States,” the Centers for Disease Control and Prevention
Combating antimicrobial resistance requires urgent development of new drugs Read More »
A new gene editing method called base editing, which could make gene editing more precise, is being clinically tested for the first time, Good
Base editing makes its clinical trial debut Read More »
